NephroPlus Q3: revenue up 32% YoY, profit up 60%; first results post listing
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.3 pts more than Nifty Microcap 250 and 8.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
First quarterly results since listing on BSE and NSE on Dec 17, 2025. Q3 FY26 consolidated revenue rose 32% year on year to Rs 259.7 cr, profit jumped 60% to Rs 32.2 cr, EPS Rs 3.43. For 9M FY26, revenue grew 37% to Rs 733.2 cr, profit up 10% to Rs 46.5 cr. India business contributed Rs 147.8 cr of Q3 revenue. Board also elevated Ravindra Tiwari to Senior Management Personnel from his existing internal audit role.
Strong first listed quarter with double-digit revenue and profit growth, positive signal for new investors.